FDA issued a Warning Letter to Altaire Pharmaceuticals, Inc. on 3/12/2020 for a later inspection.
483 Altaire Pharmaceuticals Aug 2013

483 Altaire Pharmaceuticals Aug 2013

Robert Horan FDA$119.00 - Available Now

FDA investigators audited the Altaire Pharmaceuticals - Aquebogue, NY, United States facility and issued 7 inspectional observations (via FDA 483) on 08 Aug 2013.

Product details

  • Category: Animal Drugs & Feeds / Human Drugs
  • Number of Observations: 7
  • Inspection end: 08 Aug 2013
  • Location: Aquebogue, United States
  • FEI: 1000119582
Add To Cart